NCT04107623 is a NA clinical trial of Indocyanine Green in Stomach Neoplasms, sponsored by Rigshospitalet, Denmark.

Who is sponsoring NCT04107623?

NCT04107623 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT04107623?

Interventions in NCT04107623: Indocyanine Green.

What condition does NCT04107623 study?

NCT04107623 studies Stomach Neoplasms, Surgery.

Is NCT04107623 still recruiting?

NCT04107623 is currently completed. Last updated 22 October 2021.

Last reviewed 2021-10-22 · How we verify

NCT04107623

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative Fluorescent Guided Robotic Surgery for Cancer of the Gastroesophageal Junction

Completed NA Last updated 22 October 2021

What this trial tests

NA trial testing Indocyanine Green in Stomach Neoplasms in 70 participants. Completed in 13 October 2021.

Timeline

16 June 2020

Primary endpoint
13 October 2021

13 October 2021

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	16 June 2020
Primary completion	13 October 2021
Estimated completion	13 October 2021
Sites	1 location across Denmark

Drugs / interventions tested

Indocyanine Green (INDOCYANINE GREEN) — full drug profile →

Conditions studied

Stomach Neoplasms — all drugs for Stomach Neoplasms →
Surgery — all drugs for Surgery →

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Stomach Neoplasms or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators also aim to use our previously described quantifying method (q-ICG), to evaluate changes in gastric perfusion, during resection of cancer in the gastroesophageal junction (GEJ) and if a change in the operative technique influences microvascular flow in the gastroesophageal (GE) anastomosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Potential Probes for Targeted Intraoperative Fluorescence Imaging in Gastric Cancer.
Martinelli S, Fortuna L, Coratti F, Passagnoli F, et al · · 2024 · cited 4× · PMID 39766041 · DOI 10.3390/cancers16244141

Verify or expand the search:

Other trials of Indocyanine Green

Trials testing the same drug.

NCT05038098 — Magnetic Sentinel Lymph Node Mapping in Gastric Cancer · Phase 1 · not yet recruiting
NCT07254845 — A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HIS · Phase 1 · not yet recruiting
NCT06871787 — Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery · Phase 4 · not yet recruiting
NCT06672224 — Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at · NA · withdrawn
NCT06918210 — Indocyanine Green Fluorescence During Fundus First Laparoscopic Cholecystectomy · NA · not yet recruiting

Other recruiting trials for Stomach Neoplasms

Currently open trials in the same condition.

NCT07482566 — Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer · NA · recruiting
NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
NCT07504913 — Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41 · recruiting
NCT07113340 — Carina™ Surgical Platform for Minimal Radical Gastrectomy · NA · active not recruiting
NCT06630130 — Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer · Phase 2 · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04107623 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 22 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04107623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing